{"id":579,"date":"2024-03-08T11:43:11","date_gmt":"2024-03-08T11:43:11","guid":{"rendered":"https:\/\/retirednurseblog.com\/index.php\/2024\/03\/08\/ahead-of-oscars-maker-of-blockbuster-weight-loss-drug-urges-against-vanity-use-in-new-ad-campaign\/"},"modified":"2024-03-08T11:43:11","modified_gmt":"2024-03-08T11:43:11","slug":"ahead-of-oscars-maker-of-blockbuster-weight-loss-drug-urges-against-vanity-use-in-new-ad-campaign","status":"publish","type":"post","link":"https:\/\/retirednurseblog.com\/index.php\/2024\/03\/08\/ahead-of-oscars-maker-of-blockbuster-weight-loss-drug-urges-against-vanity-use-in-new-ad-campaign\/","title":{"rendered":"Ahead of Oscars, maker of blockbuster weight loss drug urges against \u2018vanity\u2019 use in new ad campaign"},"content":{"rendered":"<div>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9em0f000j29qp7ef896ju@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            \u201cWhen I look around this room, I can\u2019t help but wonder,\u201d Academy Awards host Jimmy Kimmel joked at last year\u2019s ceremony. \u201cIs Ozempic right for me?\u201d    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25s0005356hllm52khz@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            Celebrities\u2019 use of a type 2 diabetes drug to lose weight had sparked both backlash and fascination by the time of last year\u2019s Oscars. As this year\u2019s ceremony approaches on Sunday night, the maker of a competitor set of medicines in Ozempic\u2019s class has a message for people trying to use the drugs to slim down quickly for cosmetic reasons: These aren\u2019t for you.    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25s0006356h7j47c1kl@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            \u201cSome people have been using medicine never meant for them,\u201d begins one ad from drugmaker Eli Lilly, called \u201cBig Night,\u201d which will debut on TV this weekend. \u201cFor the smaller dress or tux, for a big night, for vanity.\u201d    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25s0007356hnkmwwt5r@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            A red carpet is rolled out; paparazzi cameras flash.    <\/p>\n<div class=\"youtube\" data-uri=\"cms.cnn.com\/_components\/youtube\/instances\/clth7jwb600003b6hc82e5n14@published\" data-editable=\"settings\" data-component-name=\"youtube\">\n<aside class=\"youtube__aspect-ratio-container\">\n<div id=\"apEcQc2T\" data-video-id=\"zQWk-Q3tmkE\" class=\"youtube__content player\">\t\t<span class=\"youtube__video-title\">Big Night<\/span>\t\t\t\t<\/p>\n<div class=\"youtube__video-thumbnail-play-button\"><\/div>\n<\/p>\n<\/div>\n<\/aside>\n<\/div>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25s0008356hg9qk0nam@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            \u201cBut that\u2019s not the point,\u201d the voiceover continues as the images transition from a glitzy event to a woman dressed in ordinary clothes riding public transit. \u201cPeople whose health is affected by obesity are the reason we work on these medications. It matters who gets them.\u201d    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25s0009356hxdgw67rm@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            The ad doesn\u2019t specifically mention Lilly\u2019s drugs \u2013 Zepbound for obesity and Mounjaro for diabetes \u2013 and thus it doesn\u2019t include the litany of safety information that US TV-watchers have become accustomed to at the end of pharmaceutical commercials.    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000a356hdui9thmi@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            But it delivers a message Lilly\u2019s been trying to convey since the beginning of this year.    <\/p>\n<h2 class=\"subheader\" data-editable=\"text\" data-uri=\"cms.cnn.com\/_components\/subheader\/instances\/cltgaefdc00073b6haxhyfgpl@published\" data-component-name=\"subheader\" id=\"this-is-a-disease\" data-article-gutter=\"true\">    \u2018This is a disease\u2019<\/h2>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000c356hlemq9j19@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            Zepbound and Mounjaro are part of a class of medicines broadly referred to as GLP-1 receptor agonists, which also includes Novo Nordisk\u2019s Ozempic and its sister drug, Wegovy. Both sets of drugs mimic a hormone known as GLP-1 that reduces appetite, causes people to feel full longer and affects insulin secretion. Lilly\u2019s drugs mimic a second hormone, GIP, involved in those processes, as well.    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000d356h4cuveme6@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            Ozempic and Mounjaro are approved by the US Food and Drug Administration for diabetes, and Wegovy and Zepbound are approved for chronic weight management; in clinical trials, they were shown to help people lose 15% to 20% or more of their body weight, on average, and guidelines for their use revolve around patients\u2019 body mass index.    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000e356h7n7ixtbx@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            They\u2019re indicated for people who have a BMI of 30 or more, who are considered to have obesity, or who have a BMI of 27 \u2013 considered overweight \u2013 or higher and at least one \u201cweight-related\u201d health condition, like high blood pressure or cholesterol.    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000f356h588twe6a@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            \u201cThis is a disease,\u201d Ricks said. \u201cIt\u2019s a metabolic disorder that, for most people, won\u2019t go away without serious medical treatment. \u2026 So I don\u2019t think we\u2019re going to make much progress on this topic, that affects 100 million-plus Americans, unless we treat it like a health condition just like we do hypertension or arrhythmia or anything else.\u201d    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000g356h04ons4ej@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            Ricks detailed three reasons his company is trying to draw a line on who should get access to these drugs: insurance coverage, shortages and the people in whom they\u2019ve been studied.    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000h356h7helgi5l@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            \u201cWe\u2019ve only studied it in a population that had overweight or obesity, and we\u2019ve focused it on people with chronic complications from obesity,\u201d he said. \u201cWe can\u2019t speak to benefits and risks outside the population, so we think it\u2019s only responsible to point the light here, where the drug is most needed.\u201d    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltgfdc1n0000356hsk8v9t4p@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            Would Lilly ever study the drug for cosmetic weight loss?    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltgffitu0002356h96cunm1g@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            \u201cIt\u2019s not in our roadmap right now,\u201d Ricks said. \u201cIt\u2019s not really our mission. I think people come to work in my company and they want to solve tough health problems, not just make money in healthcare.\u201d    <\/p>\n<h2 class=\"subheader\" data-editable=\"text\" data-uri=\"cms.cnn.com\/_components\/subheader\/instances\/cltgaktle00093b6hkpz710t0@published\" data-component-name=\"subheader\" id=\"trouble-finding-paying-for-meds\" data-article-gutter=\"true\">    Trouble finding, paying for meds<\/h2>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000i356hqf97q4vp@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            Ricks also pointed out the medicines are already in shortage, and he noted the World Health Organization reported last week there are more than 1 billion people globally with obesity.    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltgfitvb0006356hac0fvdio@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            \u201cWe\u2019re a long way from being able to supply a billion people with these medications with obesity, let alone the people who may want to lose some weight cosmetically,\u201d Ricks said. \u201cSo we need to prioritize, and that\u2019s what this ad\u2019s about, is prioritizing those who need it most.\u201d    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000j356hzwrehisa@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            Lilly didn\u2019t say how many people may be using its drugs inappropriately, but the short supply of both sets of them has left people with type 2 diabetes scrambling to find their medicines. Novo Nordisk had to limit the lower starting doses of Wegovy so it could keep supplying patients already on higher maintenance doses of the drug.    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000l356hzqq2qh9x@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            And insurance coverage is poor, particularly for medicines for weight loss. They cost between $960 and $1,350 per month before insurance or discounts, and \u201chalf the people in America who have obesity\u201d don\u2019t have insurance coverage for them, Ricks said \u2013 including those covered by Medicare, which prohibits coverage of drugs for weight loss.    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000n356hxl7of8cr@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            Pressed on whether Lilly should reduce the price of the medicines to increase accessibility, Ricks pointed to discount programs the company has put in place to provide the drugs for as much as half off.    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000o356h7olhj0bo@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            But, he said, \u201cthat\u2019s not the same as insurance. And again, we don\u2019t think that a health product we\u2019ve made for a serious health condition should be uninsured. We don\u2019t accept that in any other condition.\u201d    <\/p>\n<h2 class=\"subheader\" data-editable=\"text\" data-uri=\"cms.cnn.com\/_components\/subheader\/instances\/cltga1xt500033b6hs385em86@published\" data-component-name=\"subheader\" id=\"a-goal-of-empathy\" data-article-gutter=\"true\">    A goal of empathy<\/h2>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000p356h1dlfhq0y@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            The way obesity is viewed is the subject of a second new ad from Lilly, twice as long as \u201cBig Night,\u201d called \u201cShame.\u201d    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000q356hvp8csnwm@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            \u201cIt showed up when I was young and stayed like a shadow, living in glances of people I loved and ones I didn\u2019t even know, always reminding me of my body\u2019s supposed value,\u201d the voiceover says. \u201cBut what good is shame when it comes to health? Health is not about what weight we lose; it\u2019s about all the things a body can gain.\u201d    <\/p>\n<div class=\"youtube\" data-uri=\"cms.cnn.com\/_components\/youtube\/instances\/clth7lb8z00033b6h1hlypjeb@published\" data-editable=\"settings\" data-component-name=\"youtube\">\n<aside class=\"youtube__aspect-ratio-container\">\n<div id=\"Mm4gNlxO\" data-video-id=\"lZ3Dt74R4ak\" class=\"youtube__content player\">\t\t<span class=\"youtube__video-title\">Shame<\/span>\t\t\t\t<\/p>\n<div class=\"youtube__video-thumbnail-play-button\"><\/div>\n<\/p>\n<\/div>\n<\/aside>\n<\/div>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25t000r356hr54hvqma@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            Ricks said the ad is a result of years his team spent<strong> <\/strong>with people with obesity, and its goal is to engender more empathy for them, particularly within the health-care system.    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25u000s356hya83j019@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            Lilly said the ads, which are part of a series that began this year with a focus on different diseases \u2013 including Alzheimer\u2019s, where the company expects FDA approval of a new medicine this month \u2013 would run nationally starting this weekend.    <\/p>\n<div data-uri=\"cms.cnn.com\/_components\/factbox\/instances\/cltgac14p00053b6hcu7u5375@published\" class=\"factbox_inline-small         factbox_inline-small__standard  \" data-article-gutter=\"true\">\n<ul class=\"factbox_inline-small__items factbox_inline-small__items--ul\">  <\/ul>\n<\/div>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25u000t356hh5cmgxv2@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            Will \u201cBig Night,\u201d the ad admonishing celebrities and others who use the drugs for \u201cvanity,\u201d air during the Oscars broadcast itself? Ricks said he didn\u2019t know. But, he noted, the week leading up to it is focused on advocacy, around World Obesity Day on March 4 and Obesity Care Week.    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25u000u356haai5gr62@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            \u201cIt just so happens at the end of the week is a big award show, the Oscars,\u201d he said. \u201cAnd so we\u2019re kind of seizing that moment to juxtapose those two ideas, that this is a serious condition with a serious medication.\u201d    <\/p>\n<p class=\"paragraph inline-placeholder\" data-uri=\"cms.cnn.com\/_components\/paragraph\/instances\/cltg9g25u000v356hp459mso8@published\" data-editable=\"text\" data-component-name=\"paragraph\" data-article-gutter=\"true\">            \u201cWe have to use language to talk about the condition beyond just what, you know, size dress you fit into or whatever,\u201d Ricks said. \u201cIt\u2019s not for that.\u201d    <\/p>\n<\/p>\n<div>This post appeared first on cnn.com<\/div>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>\u201cWhen I look around this room, I can\u2019t help but wonder,\u201d Academy Awards host Jimmy Kimmel joked at last year\u2019s ceremony. \u201cIs Ozempic right for me?\u201d Celebrities\u2019 use of a type 2 diabetes drug to lose weight had sparked both backlash and fascination by the time of last year\u2019s Oscars. As this year\u2019s ceremony approaches &#8230;<\/p>\n","protected":false},"author":1,"featured_media":580,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"loftocean_post_primary_category":0,"loftocean_post_format_gallery":"","loftocean_post_format_gallery_ids":"","loftocean_post_format_gallery_urls":"","loftocean_post_format_video_id":0,"loftocean_post_format_video_url":"","loftocean_post_format_video_type":"","loftocean_post_format_video":"","loftocean_post_format_audio_type":"","loftocean_post_format_audio_url":"","loftocean_post_format_audio_id":0,"loftocean_post_format_audio":"","loftocean-featured-post":"","loftocean-like-count":0,"loftocean-view-count":513,"tinysalt_single_post_intro_label":"","tinysalt_single_post_intro_description":"","tinysalt_hide_post_featured_image":"","tinysalt_post_featured_media_position":"","tinysalt_single_site_header_source":"","tinysalt_single_custom_site_header":"0","tinysalt_single_custom_sticky_site_header":"0","tinysalt_single_custom_sticky_site_header_style":"sticky-scroll-up","tinysalt_single_site_footer_source":"","tinysalt_single_custom_site_footer":"0","footnotes":""},"categories":[35],"tags":[],"class_list":["post-579","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health-news"],"_links":{"self":[{"href":"https:\/\/retirednurseblog.com\/index.php\/wp-json\/wp\/v2\/posts\/579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/retirednurseblog.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/retirednurseblog.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/retirednurseblog.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/retirednurseblog.com\/index.php\/wp-json\/wp\/v2\/comments?post=579"}],"version-history":[{"count":0,"href":"https:\/\/retirednurseblog.com\/index.php\/wp-json\/wp\/v2\/posts\/579\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/retirednurseblog.com\/index.php\/wp-json\/wp\/v2\/media\/580"}],"wp:attachment":[{"href":"https:\/\/retirednurseblog.com\/index.php\/wp-json\/wp\/v2\/media?parent=579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/retirednurseblog.com\/index.php\/wp-json\/wp\/v2\/categories?post=579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/retirednurseblog.com\/index.php\/wp-json\/wp\/v2\/tags?post=579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}